Literature DB >> 10540201

Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

H M Chapel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540201      PMCID: PMC1905384          DOI: 10.1046/j.1365-2249.1999.00000.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  34 in total

Review 1.  Gammagard and reported hepatitis C virus episodes.

Authors:  E D Gomperts
Journal:  Clin Ther       Date:  1996       Impact factor: 3.393

2.  Retrospective neuropathological review of prion disease in UK haemophilic patients.

Authors:  C A Lee; J W Ironside; J E Bell; P Giangrande; C Ludlam; M M Esiri; J E McLaughlin
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

Review 3.  Shortage of intravenous immunoglobulin.

Authors:  H Milgrom
Journal:  Ann Allergy Asthma Immunol       Date:  1998-08       Impact factor: 6.347

4.  Elimination of infectious retroviruses during preparation of immunoglobulins.

Authors:  G Mitra; M F Wong; M M Mozen; J S McDougal; J A Levy
Journal:  Transfusion       Date:  1986 Jul-Aug       Impact factor: 3.157

5.  Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study.

Authors:  S A Glynn; G B Schreiber; M P Busch; S H Kleinman; A E Williams; C C Nass; H E Ownby; J W Smith
Journal:  Transfusion       Date:  1998-04       Impact factor: 3.157

6.  Creutzfeldt-Jakob disease and blood transfusion.

Authors:  N Heye; S Hensen; N Müller
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

7.  Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database.

Authors:  J H Hoofnagle; M Lombardero; Y Wei; J Everhart; R Wiesner; R Zetterman; A J Yun; L Yang; J P Kim
Journal:  Liver Transpl Surg       Date:  1997-11

8.  Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication.

Authors:  T Laskus; L F Wang; M Radkowski; S J Jang; H Vargas; F Dodson; J Fung; J Rakela
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

9.  Detection of a novel DNA virus (TTV) in blood donors and blood products.

Authors:  P Simmonds; F Davidson; C Lycett; L E Prescott; D M MacDonald; J Ellender; P L Yap; C A Ludlam; G H Haydon; J Gillon; L M Jarvis
Journal:  Lancet       Date:  1998-07-18       Impact factor: 79.321

10.  Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.

Authors:  K Bjøro; S S Frøland; Z Yun; H H Samdal; T Haaland
Journal:  N Engl J Med       Date:  1994-12-15       Impact factor: 91.245

View more
  7 in total

1.  Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment.

Authors:  N Evangelou; T Littlewood; P Anslow; H Chapel
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 2.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

3.  Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.

Authors:  Belen Ruiz-Antorán; Antònia Agustí Escasany; Antoni Vallano Ferraz; Imma Danés Carreras; Neus Riba; Silvia Mateu Escudero; Joan Costa; M Blanca Sánchez Santiago; Leonor Laredo; José Antonio Durán Quintana; Juan Ramón Castillo; Francisco Abad-Santos; Concepción Payares Herrera; Belén Sádaba Díaz de Rada; Eugenio Gómez Ontañón
Journal:  Eur J Clin Pharmacol       Date:  2010-03-05       Impact factor: 2.953

4.  Switching immunoglobulin products, what are the implications? Result of 2018 census of immunology centres.

Authors:  Claire Bethune; Richard Herriot
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

5.  Use of Polyclonal Intravenous Immunoglobulin at a Paediatric Referral Hospital in South Africa Between 2009 and 2012.

Authors:  Shenaaz Raiman; Stephen E Knight; Brian Eley; Tyson B Welzel
Journal:  J Clin Immunol       Date:  2015-09-14       Impact factor: 8.317

6.  Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children.

Authors:  I M Balfour-Lynn; U Mohan; A Bush; M Rosenthal
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

Review 7.  Application of Antibody-Mediated Therapy for Treatment and Prevention of Clostridium difficile Infection.

Authors:  Beatrix Förster; Pui Khi Chung; Monique J T Crobach; Ed J Kuijper
Journal:  Front Microbiol       Date:  2018-06-25       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.